Emergence of an effective adaptive cell mediated immune response to Mycobacterium leprae is not impaired in reactive

Deanna A Hagge1, Vilma T Marks, Nashone A Ray

  • 1Immunology Research Department, National Hansen's Disease Programs, Laboratory Research Branch, Baton Rouge, LA 70803, USA.

Insights

Mice lacking reactive oxygen intermediates (ROI) controlled leprosy infection, demonstrating that reactive nitrogen intermediates (RNI) are crucial for host defense against Mycobacterium leprae.

Area of Science:

  • Immunology
  • Microbiology
  • Pathogenesis of infectious diseases

Background:

  • Macrophages (MPhi) use reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) to fight pathogens.
  • Leprosy is caused by Mycobacterium leprae, and the host immune response is critical for control.

Purpose of the Study:

  • To investigate the role of ROI in host defense against experimental leprosy.
  • To determine if ROI are essential for controlling Mycobacterium leprae infection.

Main Methods:

  • Used phox91-/- mice, which have a disruption in NADPH oxidase cytochrome b, lacking ROI production.
  • Infected mice with Mycobacterium leprae and analyzed foot pad granulomas and draining lymph nodes.
  • Assessed immune cell populations (CD4+, CD44, CD62L) and cytokine/chemokine expression.
  • In vitro infection of macrophages with Mycobacterium leprae.

Main Results:

  • phox91-/- mice controlled Mycobacterium leprae infection similarly to control mice, forming non-invasive granulomas.
  • Granulomas in both strains had similar cellular composition, with effector T cells (CD4+CD44(hi)CD62L(lo)).
  • In vitro, IFNgamma-activated macrophages killed M. leprae in a RNI-dependent manner, indicating ROI dispensability.

Conclusions:

  • Reactive oxygen intermediates (ROI) are dispensable for controlling Mycobacterium leprae infection.
  • Reactive nitrogen intermediates (RNI)-dependent mechanisms are sufficient for host defense against leprosy.
  • Mice lacking ROI can mount a strong adaptive immune response and control long-term infection.